Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-14 6:13 pm Purchase |
2024-10-17 | 13G | Inventiva S.A. IVA |
Andera Partners | 6,148,147 6.500% |
6,148,147 (New Position) |
Filing History |
| 2025-03-31 5:04 pm Purchase |
2024-10-17 | 13G | Inventiva S.A. IVA |
Invus Public Equities, L.P. | 7,407,406 7.800% |
7,407,406 (New Position) |
Filing History |
| 2025-03-26 4:56 pm Purchase |
2024-12-13 | 13G | Inventiva S.A. IVA |
PERCEPTIVE ADVISORS LLC | 5,555,555 5.800% |
5,555,555 (New Position) |
Filing History |
| 2025-02-14 4:20 pm Purchase |
2024-12-31 | 13G | Inventiva S.A. IVA |
Sofinnova Crossover I SLP | 7,792,307 7.200% |
1,681,480 (+27.52%) |
Filing History |
| 2025-02-14 4:05 pm Purchase |
2024-12-31 | 13G | Inventiva S.A. IVA |
Pierre Broqua | 4,097,500 4.300% |
215,000 (+5.54%) |
Filing History |
| 2024-12-23 9:25 pm Unchanged |
2024-12-19 | 13D | Inventiva S.A. IVA |
BIOTECHNOLOGY VALUE FUND L P | 8,545,499 9.000% |
0 (Unchanged) |
Filing History |
| 2024-11-13 12:26 pm Purchase |
2024-09-30 | 13G | Inventiva S.A. IVA |
Yiheng Capital Management L.P. | 4,331,196 8.310% |
1,686,270 (+63.75%) |
Filing History |
| 2024-10-21 9:00 pm Unchanged |
2024-10-17 | 13D | Inventiva S.A. IVA |
BIOTECHNOLOGY VALUE FUND L P | 8,545,499 9.800% |
0 (Unchanged) |
Filing History |
| 2024-10-21 8:54 pm Purchase |
2024-10-17 | 13D | Inventiva S.A. IVA |
New Enterprise Associates 17, L.P. | 7,835,884 9.000% |
2,262,931 (+40.61%) |
Filing History |
| 2024-07-19 4:30 pm Unchanged |
2024-07-17 | 13D | Inventiva S.A. IVA |
BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.300% |
0 (Unchanged) |
Filing History |
| 2024-05-03 9:22 pm Purchase |
2024-04-03 | 13D | Inventiva S.A. IVA |
New Enterprise Associates 17, L.P. | 5,572,953 10.700% |
420,920 (+8.17%) |
Filing History |
| 2024-02-14 4:08 pm Unchanged |
2023-12-31 | 13G | Inventiva S.A. IVA |
Yiheng Capital Management L.P. | 2,644,926 6.280% |
0 (Unchanged) |
Filing History |
| 2024-02-09 4:49 pm Purchase |
2023-12-31 | 13G | Inventiva S.A. IVA |
Sofinnova Crossover I SLP | 6,110,827 9.700% |
2,728,888 (+80.69%) |
Filing History |
| 2023-09-25 4:35 pm Purchase |
2023-08-31 | 13D | Inventiva S.A. IVA |
BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.500% |
587,361 (+7.38%) |
Filing History |
| 2023-09-05 4:58 pm Purchase |
2023-08-30 | 13G | Inventiva S.A. IVA |
Qatar Investment Authority | 5,157,233 9.970% |
5,157,233 (New Position) |
Filing History |
| 2023-02-14 4:08 pm Purchase |
2022-12-31 | 13G | Inventiva S.A. IVA |
Yiheng Capital Management L.P. | 2,644,926 6.470% |
2,644,926 (New Position) |
Filing History |
| 2023-02-13 2:07 pm Purchase |
2022-12-31 | 13G | Inventiva S.A. IVA |
Sofinnova Crossover I SLP | 3,381,939 8.000% |
129,032 (+3.97%) |
Filing History |
| 2022-02-11 12:00 pm Purchase |
2021-12-31 | 13G | Inventiva S.A. IVA |
Sofinnova Crossover I SLP | 3,252,907 6.200% |
138,880 (+4.46%) |
Filing History |
| 2021-02-10 4:15 pm Purchase |
2020-12-31 | 13G | Inventiva S.A. IVA |
Pierre Broqua | 3,882,500 10.100% |
3,882,500 (New Position) |
Filing History |
| 2021-02-10 4:15 pm Purchase |
2020-12-31 | 13G | Inventiva S.A. IVA |
Cren Frederic | 5,612,224 14.600% |
5,612,224 (New Position) |
Filing History |